Paul Bevan
Impact in
-
- Neurotransmitter Receptor Influence on Behavior
- Neuroscience and Neuropharmacology Research
-
- Behavioral and Psychological Studies
Papers in
-
- Receptor Mechanisms and Signaling 9
-
- Neuroscience and Neuropharmacology Research 15
- Neurotransmitter Receptor Influence on Behavior 10
- Neuroscience and Neural Engineering 4
- Co-authors
- E. Szabadi (34 shared papers)C. M. Bradshaw (33 shared papers)Trevor Archer (1 shared paper)A.R. Cools (1 shared paper)C. Mala (10 shared papers)Ian Shaw (1 shared paper)Hamish Ryder (1 shared paper)Peter Charlton (6 shared papers)
- Journals
- Journal of Clinical Oncology (9 papers)British Journal of Pharmacology (9 papers)Journal of Pharmacy and Pharmacology (3 papers)Neuropharmacology (3 papers)Brain Research (2 papers)
- Partner nations
- United KingdomGermanyUnited States
In The Last Decade
Paul Bevan
73 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 134
- Cellular and Molecular Neuroscience 557
- Developmental and Educational Psychology 335
- Cancer Research 277
- Cognitive Neuroscience 357
- Hematology 117
Countries citing papers authored by Paul Bevan
This map shows the geographic impact of Paul Bevan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Bevan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Bevan more than expected).
Fields of papers citing papers by Paul Bevan
This network shows the impact of papers produced by Paul Bevan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Bevan. The network helps show where Paul Bevan may publish in the future.
Co-authors
The 25 scholars most cited alongside Paul Bevan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 76 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 163 | |
| 2 | 1989 | 124 | |
| 3 | 1976 | 103 | |
| 4 | 2016 | 99 | |
| 5 | 1977 | 90 | |
| 6 | 1990 | 80 | |
| 7 | Novel low-molecular-weight inhibitor of PAI-1 (XR5118) promotes endogenous fibrinolysis and reduces postthrombolysis thrombus growth in rabbits. | 1997 | 78 |
| 8 | 1978 | 68 | |
| 9 | 1995 | 67 | |
| 10 | 1996 | 66 | |
| 11 | 2019 | 66 | |
| 12 | 2013 | 66 | |
| 13 | 1975 | 56 | |
| 14 | 2018 | 50 | |
| 15 | 1979 | 48 | |
| 16 | 1983 | 45 | |
| 17 | 1977 | 38 | |
| 18 | 2013 | 37 | |
| 19 | 1978 | 36 | |
| 20 | 1977 | 35 |
About Paul Bevan
Paul Bevan is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience, Cognitive Neuroscience, Cancer Research and Developmental and Educational Psychology, having authored 76 papers that have together received 2.0k indexed citations. Recurring topics across this work include Neuroscience and Neuropharmacology Research (15 papers), Neurotransmitter Receptor Influence on Behavior (10 papers), Receptor Mechanisms and Signaling (9 papers), Behavioral and Psychological Studies (9 papers), Protease and Inhibitor Mechanisms (7 papers), Autism Spectrum Disorder Research (6 papers), Renal cell carcinoma treatment (5 papers) and Neuroscience and Neural Engineering (4 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (557 citations), Developmental and Educational Psychology (335 citations), Cancer Research (277 citations), Cognitive Neuroscience (357 citations) and Hematology (117 citations). Paul Bevan has collaborated with scholars based in United Kingdom, Germany and United States. Frequent co-authors include E. Szabadi, C. M. Bradshaw, Trevor Archer, A.R. Cools, C. Mala, Ian Shaw, Hamish Ryder, Peter Charlton, Arie S. Belldegrun and P. R. Saxena. Their work appears in journals such as Journal of Clinical Oncology, British Journal of Pharmacology, Journal of Pharmacy and Pharmacology, Neuropharmacology and Brain Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.